Published in Br J Pharmacol on May 14, 2007
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol (2008) 3.39
Cholinergic control of inflammation. J Intern Med (2009) 2.12
Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations. Biochem Pharmacol (2011) 1.68
High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther (2008) 1.65
Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress. PLoS One (2014) 1.52
Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gut injury and lymph toxicity in trauma and hemorrhagic shock. Shock (2013) 1.51
Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis (2008) 1.45
Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg (2010) 1.41
Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum (2008) 1.34
Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med (2011) 1.32
α7-cholinergic receptor mediates vagal induction of splenic norepinephrine. J Immunol (2011) 1.25
Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J Cell Mol Med (2008) 1.22
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci (2010) 1.20
Targeting Abeta and tau in Alzheimer's disease, an early interim report. Exp Neurol (2009) 1.18
Merging old and new perspectives on nicotinic acetylcholine receptors. Biochem Pharmacol (2014) 1.14
The vagal innervation of the gut and immune homeostasis. Gut (2012) 1.12
Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther (2009) 1.12
The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.10
Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther (2010) 1.08
CHRFAM7A, a human-specific and partially duplicated α7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury. J Leukoc Biol (2014) 1.05
The effective opening of nicotinic acetylcholine receptors with single agonist binding sites. J Gen Physiol (2011) 1.04
β2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system. FASEB J (2011) 1.03
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists. J Pharmacol Exp Ther (2011) 1.03
Intrinsically low open probability of α7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures. Mol Pharmacol (2012) 1.03
Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis. J Immunol (2011) 1.02
α7 nicotinic acetylcholine receptor agonism confers neuroprotection through GSK-3β inhibition in a mouse model of intracerebral hemorrhage. Stroke (2011) 1.02
Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol (2010) 1.02
JAK2 inhibition prevents innate immune responses and rescues animals from sepsis. J Mol Med (Berl) (2010) 1.01
Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol (2011) 1.01
α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J Neuroinflammation (2012) 0.98
Involvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One (2013) 0.98
Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med (2011) 0.96
Ultrasound Modulates the Splenic Neuroimmune Axis in Attenuating AKI. J Am Soc Nephrol (2015) 0.96
The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor. Neuropharmacology (2014) 0.96
The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models. J Pharmacol Exp Ther (2012) 0.95
Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors. J Pharmacol Exp Ther (2008) 0.95
The minimal pharmacophore for silent agonism of the α7 nicotinic acetylcholine receptor. J Pharmacol Exp Ther (2014) 0.94
Synthesis and evaluation of a conditionally-silent agonist for the α7 nicotinic acetylcholine receptor. Bioorg Med Chem Lett (2013) 0.94
Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models. Neuropharmacology (2012) 0.94
PHA-543613 preserves blood-brain barrier integrity after intracerebral hemorrhage in mice. Stroke (2013) 0.93
Nicotine exerts an anti-inflammatory effect in a murine model of acute lung injury. Inflammation (2011) 0.91
Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility. World J Gastroenterol (2010) 0.91
Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease. J Immunol (2015) 0.90
Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A. Proc Natl Acad Sci U S A (2013) 0.90
The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function. Neuropharmacology (2015) 0.90
Crohn's disease as an immunodeficiency. Expert Rev Clin Immunol (2010) 0.89
Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors. Int Immunopharmacol (2009) 0.89
Lipopolysaccharide upregulates α7 acetylcholine receptors: stimulation with GTS-21 mitigates growth arrest of macrophages and improves survival in burned mice. Shock (2012) 0.89
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders. Cell Mol Life Sci (2016) 0.88
Smoking and impaired bone healing: will activation of cholinergic anti-inflammatory pathway be the bridge? Int Orthop (2011) 0.88
Puerarin partly counteracts the inflammatory response after cerebral ischemia/reperfusion via activating the cholinergic anti-inflammatory pathway. Neural Regen Res (2013) 0.88
Looking below the surface of nicotinic acetylcholine receptors. Trends Pharmacol Sci (2015) 0.87
Effects of lipid-analog detergent solubilization on the functionality and lipidic cubic phase mobility of the Torpedo californica nicotinic acetylcholine receptor. J Membr Biol (2011) 0.87
Tethered agonist analogs as site-specific probes for domains of the human α7 nicotinic acetylcholine receptor that differentially regulate activation and desensitization. Mol Pharmacol (2010) 0.87
In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model. Br J Pharmacol (2013) 0.87
Evidence for a prosurvival role of alpha-7 nicotinic acetylcholine receptor in alternatively (M2)-activated macrophages. Physiol Rep (2013) 0.86
A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors. J Neurochem (2009) 0.86
ELIC-α7 Nicotinic acetylcholine receptor (α7nAChR) chimeras reveal a prominent role of the extracellular-transmembrane domain interface in allosteric modulation. J Biol Chem (2014) 0.86
Cholinergic regulation of airway inflammation and remodelling. J Allergy (Cairo) (2012) 0.86
Strain dependent effects of prenatal stress on gene expression in the rat hippocampus. Physiol Behav (2011) 0.85
Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation. Ann N Y Acad Sci (2014) 0.84
Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases. Br J Pharmacol (2015) 0.84
Anti-allergic role of cholinergic neuronal pathway via α7 nicotinic ACh receptors on mucosal mast cells in a murine food allergy model. PLoS One (2014) 0.84
Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain. Front Mol Neurosci (2016) 0.84
Postconditioning with α7nAChR agonist attenuates systemic inflammatory response to myocardial ischemia--reperfusion injury in rats. Inflammation (2012) 0.83
Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice. PLoS One (2015) 0.83
Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats. Brain Behav Immun (2010) 0.83
Sperm epidermal growth factor receptor (EGFR) mediates α7 acetylcholine receptor (AChR) activation to promote fertilization. J Biol Chem (2012) 0.83
Neuronal nicotinic alpha7 receptors modulate early neutrophil infiltration to sites of skin inflammation. J Neuroinflammation (2010) 0.82
The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface. J Biol Chem (2013) 0.82
Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells. J Stem Cells (2009) 0.82
Multiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents. Mol Pharmacol (2013) 0.82
Synthesis of H-bonding probes of alpha7 nAChR agonist selectivity. Bioorg Med Chem Lett (2008) 0.82
A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia. Fitoterapia (2014) 0.82
Functional Impact of 14 Single Nucleotide Polymorphisms Causing Missense Mutations of Human α7 Nicotinic Receptor. PLoS One (2015) 0.82
Nicotinic receptor subunit alpha5 modifies assembly, up-regulation, and response to pro-inflammatory cytokines. J Biol Chem (2010) 0.81
GTS-21, an α7-nicotinic acetylcholine receptor agonist, modulates Th1 differentiation in CD4(+) T cells from patients with rheumatoid arthritis. Exp Ther Med (2014) 0.81
Anti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytes. Biomed Res Int (2014) 0.81
Effects of combined anisodamine and neostigmine treatment on the inflammatory response and liver regeneration of obstructive jaundice rats after hepatectomy. Biomed Res Int (2014) 0.81
An unusual pattern of ligand-receptor interactions for the α7 nicotinic acetylcholine receptor, with implications for the binding of varenicline. Mol Pharmacol (2013) 0.81
Inflammatory response to burn trauma: nicotine attenuates proinflammatory cytokine levels. Eplasty (2014) 0.81
{alpha}7-nAChR-mediated suppression of hyperexcitability of colonic dorsal root ganglia neurons in experimental colitis. Am J Physiol Gastrointest Liver Physiol (2010) 0.80
Nicotinic receptor Alpha7 expression during mouse adrenal gland development. PLoS One (2014) 0.80
Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain. Bioorg Med Chem (2012) 0.80
Vagal nerve stimulation modulates gut injury and lung permeability in trauma-hemorrhagic shock. J Trauma Acute Care Surg (2012) 0.80
α7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid β42 accumulation in the mouse brain to impair memory. PLoS One (2015) 0.80
Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates. Mol Pharmacol (2012) 0.80
Phospholipase C activity affinity purifies with the Torpedo nicotinic acetylcholine receptor. J Biol Chem (2010) 0.80
The intestinal cholinergic anti-inflammatory pathway. J Physiol (2016) 0.80
Dimeric α-cobratoxin X-ray structure: localization of intermolecular disulfides and possible mode of binding to nicotinic acetylcholine receptors. J Biol Chem (2012) 0.79
Novel information on the non-neuronal cholinergic system in orthopedics provides new possible treatment strategies for inflammatory and degenerative diseases. Orthop Rev (Pavia) (2009) 0.79
The interface between cholinergic pathways and the immune system and its relevance to arthritis. Arthritis Res Ther (2015) 0.79
The potential application of nicotinic acetylcholine receptor agonists for the treatment of rheumatoid arthritis. Inflamm Res (2010) 0.79
Neuregulin upregulates microglial α7 nicotinic acetylcholine receptor expression in immortalized cell lines: implications for regulating neuroinflammation. PLoS One (2013) 0.78
Role of α7 nicotinic receptor in the immune system and intracellular signaling pathways. Cent Eur J Immunol (2015) 0.78
Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3. Sci Rep (2015) 0.78
The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice. Anesth Analg (2015) 0.78
Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine Receptors. Assay Drug Dev Technol (2016) 0.78
PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates. Eur J Nucl Med Mol Imaging (2015) 0.77
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
The inflammatory reflex. Nature (2002) 9.10
Structure and gating mechanism of the acetylcholine receptor pore. Nature (2003) 8.30
Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity (1999) 7.90
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med (2004) 6.38
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol (2005) 4.91
What does Stat3 do? J Clin Invest (2002) 4.83
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med (2001) 4.56
Effects of cigarette smoke on the immune system. Nat Rev Immunol (2002) 4.38
Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol (2002) 4.37
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet (1998) 4.05
Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med (2006) 3.66
Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature (1999) 3.59
Microglia as neuroprotective, immunocompetent cells of the CNS. Glia (2002) 3.12
Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med (2005) 3.01
The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med (1967) 2.99
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem (2000) 2.96
Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem (1995) 2.95
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
The "cytokine profile": a code for sepsis. Trends Mol Med (2005) 2.89
Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med (2002) 2.83
Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem (1999) 2.79
Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel. Nature (2004) 2.77
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev (1999) 2.76
The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci U S A (2005) 2.74
Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry (2006) 2.63
The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov (2005) 2.57
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology (2006) 2.47
High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev (2006) 2.26
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) (2004) 2.19
Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proc Natl Acad Sci U S A (1993) 2.14
Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med (2005) 2.06
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem (2004) 1.99
Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation (2003) 1.98
Interleukin-10 suppression of myeloid cell activation--a continuing puzzle. Immunology (2004) 1.95
Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J (2002) 1.86
Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med (2005) 1.81
New concepts in chronic obstructive pulmonary disease. Annu Rev Med (2001) 1.75
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology (2006) 1.75
Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol (2001) 1.74
Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J (2006) 1.67
The innate signaling of dangers and the dangers of innate signaling. Nat Immunol (2006) 1.61
Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther (2000) 1.60
STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood (2004) 1.58
Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol (2004) 1.56
The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci (2003) 1.55
Functional significance of aromatic amino acids from three peptide loops of the alpha 7 neuronal nicotinic receptor site investigated by site-directed mutagenesis. FEBS Lett (1991) 1.54
Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci (2004) 1.53
Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J (2006) 1.52
Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology (2002) 1.48
Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem (2000) 1.47
Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells. J Biol Chem (2004) 1.46
Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem (2003) 1.45
Mechanisms of disease: nicotine--a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol (2005) 1.39
Therapeutic intervention and targets for sepsis. Annu Rev Med (2005) 1.38
Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. J Neurosci (2000) 1.37
Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics (1998) 1.36
Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation (2005) 1.36
Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. J Neurobiol (2002) 1.34
Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock (1995) 1.32
Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res (2006) 1.32
Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology (2003) 1.31
Review article: Infliximab therapy for inflammatory bowel disease--seven years on. Aliment Pharmacol Ther (2006) 1.31
Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol (2002) 1.31
Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci (2005) 1.30
Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol Today (2000) 1.29
Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J Biol Chem (2002) 1.21
Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett (1999) 1.20
Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science (1984) 1.18
Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation. Biochem Biophys Res Commun (1998) 1.18
Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet B Neuropsychiatr Genet (2003) 1.17
The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and inducible nitric oxide synthase transrepression in mesangial cells. J Am Soc Nephrol (2004) 1.17
Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. J Pharmacol Exp Ther (1998) 1.16
Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol (2000) 1.14
Rat lymphocytes produce and secrete acetylcholine in dependence of differentiation and activation. J Neuroimmunol (1998) 1.13
Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol (2006) 1.12
Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kappaB. J Leukoc Biol (2003) 1.10
Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock (2006) 1.09
Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors. Neuropharmacology (2005) 1.08
Neuronal alpha-bungarotoxin receptors differ structurally from other nicotinic acetylcholine receptors. J Neurosci (1997) 1.07
Medical treatment of inflammatory bowel diseases. Curr Opin Gastroenterol (2005) 1.05
Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut (1994) 1.05
Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv Pharmacol (1997) 1.01
Nicotine prolongs neutrophil survival by suppressing apoptosis. J Lab Clin Med (1996) 1.00
Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology (1998) 0.99
Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J Neurochem (2001) 0.97
Decline in the phagocytic function of alveolar macrophages from mice exposed to cigarette smoke. Comp Immunol Microbiol Infect Dis (1994) 0.97
Effect of smoking and abstention on oxidative burst and reactivity of neutrophils and monocytes. Surgery (2004) 0.97
Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiol Dis (2004) 0.96
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site. J Neurosci (2005) 0.96
Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunol Lett (2004) 0.94
Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes. J Neuroimmunol (2002) 0.94
The molecular biology of neuronal nicotinic acetylcholine receptors. Crit Rev Toxicol (1997) 0.94
Nicotinic receptors regulate B lymphocyte activation and immune response. Eur J Pharmacol (2005) 0.93
Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation. Am J Physiol Lung Cell Mol Physiol (2006) 0.93
High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum (2002) 2.45
Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. Cochrane Database Syst Rev (2007) 1.43
Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. J Cell Sci (1997) 0.98
Phosphorylation of microtubule-associated proteins by protein kinase CK2 in neuritogenesis. Cell Mol Biol Res (1994) 0.87
Characterization of microtubule-associated protein MAP1B: phosphorylation state, light chains, and binding to microtubules. Biochemistry (1996) 0.84
Role of phosphorylated MAPlB in neuritogenesis. Cell Biol Int (1994) 0.78
NMDA-glutamate receptors regulate phosphorylation of dendritic cytoskeletal proteins in the hippocampus. Brain Res (1997) 0.77
The phosphorylated isoform of microtubule associated protein 1B (MAP1B) is expressed in the visual system of the tench (Tinca tinca, L) during optic nerve regeneration. Neurosci Lett (1998) 0.75
Phosphorylated microtubule associated protein (MAP1B-Phos) in the retina during regeneration of the fish optic nerve. Int J Dev Biol (1996) 0.75